Skip to main content
. 2023 Mar 24;15:1132723. doi: 10.3389/fnagi.2023.1132723

TABLE 1.

Demographic and clinical information of patients with Parkinson’s disease and healthy controls.

EOPD YCs LOPD OCs P-value
EOPD VS. YCs LOPD VS. OCs EOPD VS. LOPD
Gender (Female) 28 (13) 25 (18) 22 (12) 24 (12) 0.06 0.758 0.569
Agea 47.25 ± 5.64 48.64 ± 2.87 58.22 ± 3.29 58.37 ± 3.80 0.258 0.889 <0.001*
Age of Onsetb 44.53 ± 4.84 NA 55.86 ± 3.41 NA NA NA <0.001*
Durationb, years 2.78 ± 2.83 NA 2.35 ± 1.57 NA NA NA 0.929
Educationa, years 8.32 ± 3.38 9.04 ± 2.96 7.36 ± 4.39 7.22 ± 3.61 0.418 0.91 0.388
Modified H-Y stageb 1.68 ± 0.63 NA 1.95 ± 0.57 NA NA NA 0.146
Total scores of UPDRSb 26.25 ± 17.37 NA 34.59 ± 21.45 NA NA NA 0.137
Scores of UPDRS-IIIb 16.57 ± 11.55 NA 22.64 ± 15.50 NA NA NA 0.177
MMSEb 27.68 ± 2.07 28.08 ± 2.34 25.41 ± 2.71 25.87 ± 3.50 0.199 0.513 0.004*

All data are presented as Median ± SD. EOPD, early-onset Parkinson’s disease; LOPD, late-onset Parkinson’s disease; YCs, young controls; OCs, old controls; H-Y stage, Hoehn and Yahr stage; UDPRS, Unified Parkinson’s Disease Rating Scale; MMSE, Mini-Mental State Examination; UDPRS-III, the third part of Unified Parkinson’s Disease Rating Scale. The chi-square test was performed for comparing gender differences between groups, Other data were compared between groups using two-sample t-test or Mann–Whitney U test.

aRepresents two-sample t-test.

bRepresents Mann–Whitney U test.

*Represent a significance at P < 0.05.